Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Rating)'s share price dropped 6.5% on Wednesday after an insider sold shares in the company. The stock traded as low as $38.63 and last traded at $38.70. Approximately 13,849 shares changed hands during trading, a decline of 97% from the average daily volume of 530,090 shares. The stock had previously closed at $41.41.Specifically, Director Howard Lee sold 10,291 shares of the stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $37.79, for a total value of $388,896.89. Following the completion of the sale, the director now owns 138,776 shares in the company, valued at $5,244,345.04. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jack Y. Zhang sold 67,046 shares of the stock in a transaction dated Wednesday, May 18th. The shares were sold at an average price of $34.14, for a total transaction of $2,288,950.44. Following the transaction, the chief executive officer now owns 2,156,523 shares of the company's stock, valued at approximately $73,623,695.22. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 126,747 shares of company stock worth $4,398,003. Insiders own 27.80% of the company's stock.
https://www.marketbeat.com/instant-alerts/nasdaq-amph-percent-decline-2022-06/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.